Mohini Health & Hygiene Ltd

As of November 18, 2025, Mohini Health is considered overvalued with a PE Ratio of 12.76 and an EV to EBITDA of 9.50, reflecting a shift to an expensive valuation grade, especially in comparison to peers like Altius Telecom, while its year-to-date return of -19.34% significantly underperforms the Sensex's gain of 9.58%.

As of 18-Nov, Mohini Health & Hygiene Ltd's stock is at Rs. 41.50, down 4.05% and hitting a 52-week low. The stock has underperformed its sector and the broader market, with a year-to-date decline of 19.34% and a bearish trend indicated by trading below all major moving averages.

As of November 14, 2025, Mohini Health is fairly valued with a PE ratio of 13.96, significantly lower than its peers, making it a potentially more attractive investment despite a year-to-date stock decline of 11.76%.

As of November 14, 2025, Mohini Health is fairly valued with a PE ratio of 13.96, an EV to EBITDA of 8.79, and a Price to Book Value of 0.79, indicating better value compared to peers like Altius Telecom and Sagility, despite a year-to-date return of -11.76% against the Sensex's 9.58%.

As of November 14, 2025, Mohini Health is fairly valued with a PE ratio of 13.96, significantly lower than its peers, indicating potential for recovery despite recent underperformance against the Sensex.

Mohini Health's historical performance shows a decline in net sales from INR 199.61 crore in March 2024 to INR 167.77 crore in March 2025, despite some improvements in profit metrics. The consolidated net profit dropped significantly to INR 5.85 crore in March 2025, raising concerns about revenue generation capabilities.

As of 14-Nov, Mohini Health & Hygiene Ltd's stock price is Rs 45.40, down 4.72% and near its 52-week low. The stock has underperformed its sector and the broader market significantly, with notable declines over the past week, month, and year-to-date, despite increased investor interest.

As of November 13, 2025, Mohini Health is considered overvalued with a PE ratio of 14.65 and an EV to EBITDA of 9.13, lagging behind its peers and the Sensex, which raises concerns about its investment attractiveness.

As of 28-Oct, Mohini Health & Hygiene Ltd's stock price is declining at Rs. 46.00, down 2.54%, and has reached a 52-week low. Despite a strong long-term performance, recent trends show significant declines in both year-to-date and one-year returns, indicating a bearish outlook compared to the broader market.

As of 23-Oct, Mohini Health & Hygiene Ltd is priced at 48.50, showing a bearish trend with a 5.46% decline over the past week and a year-to-date drop of 5.73%. The stock is underperforming compared to the broader market, which has seen positive gains, indicating a lack of investor confidence.

As of 24-Sep, Mohini Health & Hygiene Ltd's stock price is declining at 51.30, down 1.16%, and trading below all key moving averages, indicating a bearish trend. Investor participation has significantly dropped, and the stock has underperformed both in the past week and year compared to the benchmark index.

As of September 23, 2025, Mohini Health is considered overvalued with a PE ratio of 15.96 and an EV to EBITDA of 9.55, despite having a lower PE than Altius Telecom and a more favorable EV to EBITDA than some competitors, while also underperforming against the Sensex over the past year.

As of 23-Sep, Mohini Health & Hygiene Ltd is priced at 51.90, down 0.95%, and has underperformed its sector and the Sensex. Despite a recent increase in investor participation, the stock has declined significantly over the past week and month, reflecting ongoing challenges in its performance.

As of September 22, 2025, Mohini Health is considered undervalued with a valuation grade upgrade to attractive, reflected by a PE ratio of 15.99, an EV to EBITDA ratio of 9.56, and a price to book value of 0.94, especially when compared to peers like Altius Telecom and Embassy Off.REIT, despite a 12.74% decline in its stock over the past year.

As of 22-Sep, Mohini Health & Hygiene Ltd is priced at 52.40, down 1.13%, and has underperformed its sector while trading below key moving averages. The stock has seen a significant drop in investor participation and has declined 1.32% over the past week and 4.12% over the past month, contrasting with the Sensex's gains.

As of 19-Sep, Mohini Health & Hygiene Ltd's stock price is declining at 53.00, down 1.3%, and underperforming its sector. Despite a positive year-to-date return of 3.01%, recent trends indicate significant short-term struggles, including a 41.18% drop in investor participation.

As of 18-Sep, Mohini Health & Hygiene Ltd's stock price is at 53.70, with a recent mixed performance, showing a 1-week return of +0.75% and a month decline of 4.96%. Despite short-term underperformance compared to the Sensex, the stock has strong long-term growth with a 5-year return of +214.96%.

As of September 17, 2025, Mohini Health is fairly valued with a PE ratio of 16.48 and an EV to EBITDA of 9.81, making it more reasonably priced compared to peers like Altius Telecom and Embassy Office REIT, despite its year-to-date stock performance lagging behind the Sensex.

As of 17-Sep, Mohini Health & Hygiene Ltd's stock price is at 53.60, down 1.65%, and has underperformed its sector by 2.18%. Despite a positive three-year return of 43.89%, it has declined 11.40% over the past year, reflecting weaker performance compared to the broader market.